ARWR: License and Collaboration Deal with Sarepta Includes …
22 hours ago · On November 26, 2024, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced a global license and collaboration agreement with Sarepta Therapeutics (SRPT) in which Arrowhead is set to receive ...
Arrowhead Pharmaceuticals Announces Global License and …
Nov 26, 2024 · Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). Upon closing, Arrowhead will receive $825 million, consisting of $500 million cash and $325 million as an equity investment priced at a 35% premium.
Arrowhead Pharmaceuticals Nabs Massive Sarepta Licensing Deal; ARWR …
Nov 26, 2024 · Arrowhead shares rocketed 12% to close at 21.05 and ARWR stock leapfrogged its 50-day line, according to MarketSurge. ... Related news Sarepta Therapeutics Sees RS Rating Rise To 75.
Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta …
Nov 26, 2024 · Arrowhead (ARWR) announced a global licensing and collaboration agreement with Sarepta (SRPT). Upon closing, Arrowhead will receive $825M, consisting of $500M cash and $325M as an equity ...
Sarepta to pay Arrowhead $500M + in licensing deal for siRNA …
Nov 26, 2024 · Sarepta Therapeutics (SRPT), the leader in precision genetic medicine for rare diseases announced an exclusive global licensing and collaboration agreement with Arrowhead (ARWR) Pharmaceuticals...
Arrowhead Pharma Inks Licensing Deal With Sarepta, Stock Jumps
Nov 26, 2024 · (RTTNews) - Arrowhead Pharmaceuticals (ARWR), a clinical-stage biotech company, announced, on Tuesday, that it has entered into a global licensing and collaboration agreement with Sarepta...
Sarepta Therapeutics, Arrowhead Pharmaceuticals Ink …
Nov 26, 2024 · Sarepta will secure exclusive global rights to multiple programs for rare genetic diseases affecting muscles, the central nervous systems and lungs, the company said. Sarepta Chief Executive Doug...
Sarepta Inks Global Licensing Deal With Arrowhead, Announces …
Nov 26, 2024 · (RTTNews) - Sarepta Therapeutics, Inc. (SRPT), Tuesday announced a global licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. (ARWR) for multiple clinical, pre-clinical, and ...
ARWR: License and Collaboration Deal with Sarepta Includes …
1 day ago · On November 26, 2024, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced a global license and collaboration agreement with Sarepta Therapeutics (SRPT) in which Arrowhead is set to receive $825 million, consisting of $500 million in cash and $325 million as an equity investment priced at a 35% premium. The agreement covers the following assets:
Arrowhead climbs after licensing deal with Sarepta - MSN
Sarepta is also expected to provide ARWR with $250M, to be paid over five years in annual installments of $50M, and name its president and CEO Doug Ingram to Arrowhead’s (NASDAQ:ARWR) board.As ...